Berliner Boersenzeitung - Moderna seeks US authorization for Covid vaccine in children under 6: statement

EUR -
AED 4.26841
AFN 80.362394
ALL 97.542216
AMD 446.735356
ANG 2.080099
AOA 1065.794205
ARS 1494.414015
AUD 1.776887
AWG 2.092071
AZN 1.980459
BAM 1.954642
BBD 2.348809
BDT 141.226338
BGN 1.956132
BHD 0.43854
BIF 3466.946195
BMD 1.162261
BND 1.493215
BOB 8.038238
BRL 6.486005
BSD 1.163311
BTN 100.147673
BWP 15.618748
BYN 3.807045
BYR 22780.325028
BZD 2.336716
CAD 1.596076
CDF 3354.287055
CHF 0.932807
CLF 0.029182
CLP 1120.296341
CNY 8.342655
CNH 8.346165
COP 4674.330945
CRC 587.052233
CUC 1.162261
CUP 30.799929
CVE 110.199718
CZK 24.634179
DJF 206.947405
DKK 7.463699
DOP 70.258379
DZD 151.514244
EGP 57.439973
ERN 17.433922
ETB 161.636047
FJD 2.620788
FKP 0.864949
GBP 0.866519
GEL 3.150183
GGP 0.864949
GHS 12.127816
GIP 0.864949
GMD 83.106172
GNF 10094.020343
GTQ 8.931709
GYD 243.385819
HKD 9.121487
HNL 30.445964
HRK 7.532663
HTG 152.739518
HUF 398.923459
IDR 18977.696027
ILS 3.908598
IMP 0.864949
INR 100.127437
IQD 1523.897249
IRR 48945.741055
ISK 142.354235
JEP 0.864949
JMD 186.029797
JOD 0.824089
JPY 172.932309
KES 150.300962
KGS 101.640213
KHR 4662.238109
KMF 491.989694
KPW 1046.046309
KRW 1616.942576
KWD 0.355234
KYD 0.969426
KZT 620.152624
LAK 25087.138481
LBP 104232.653
LKR 350.972086
LRD 233.241828
LSL 20.596898
LTL 3.431856
LVL 0.703041
LYD 6.327252
MAD 10.519168
MDL 19.788278
MGA 5176.933206
MKD 61.523554
MMK 2439.678938
MNT 4168.013035
MOP 9.404829
MRU 46.275587
MUR 53.119698
MVR 17.903172
MWK 2017.205016
MXN 21.777182
MYR 4.935007
MZN 74.338683
NAD 20.596898
NGN 1779.387897
NIO 42.814637
NOK 11.838157
NPR 160.236077
NZD 1.94976
OMR 0.446894
PAB 1.163311
PEN 4.140847
PGK 4.817146
PHP 66.377189
PKR 331.310933
PLN 4.244785
PYG 9003.666265
QAR 4.229694
RON 5.072695
RSD 117.080642
RUB 91.265035
RWF 1681.00418
SAR 4.36165
SBD 9.64543
SCR 17.082281
SDG 697.942292
SEK 11.245095
SGD 1.492813
SHP 0.913355
SLE 26.62005
SLL 24372.046713
SOS 664.806172
SRD 43.245469
STD 24056.466061
STN 24.485495
SVC 10.17897
SYP 15112.803405
SZL 20.592801
THB 37.628259
TJS 11.196867
TMT 4.079538
TND 3.419874
TOP 2.722137
TRY 46.947496
TTD 7.897322
TWD 34.181766
TZS 3030.404801
UAH 48.58252
UGX 4168.530579
USD 1.162261
UYU 46.882227
UZS 14725.276806
VES 135.943958
VND 30404.760344
VUV 138.92149
WST 3.080055
XAF 655.568644
XAG 0.030448
XAU 0.000347
XCD 3.14107
XCG 2.096558
XDR 0.815317
XOF 655.568644
XPF 119.331742
YER 280.163552
ZAR 20.586499
ZMK 10461.752209
ZMW 26.785133
ZWL 374.247723
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

Moderna seeks US authorization for Covid vaccine in children under 6: statement
Moderna seeks US authorization for Covid vaccine in children under 6: statement / Photo: Eugene Hoshiko - POOL/AFP

Moderna seeks US authorization for Covid vaccine in children under 6: statement

US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.

Text size:

Children under six are the only age group that has yet to gain access to a Covid-19 vaccine in the United States and in most countries.

"We believe (this vaccine) will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against Covid-19 and will be especially welcomed by parents and caregivers," the company's CEO Stephane Bancel said in a statement.

In March, the company announced results from a trial that showed the two-shot regimen was found to be safe and produced a strong immune response.

Specifically, two doses of 25 micrograms given to babies, toddlers and preschoolers generated similar levels of antibodies as two doses of 100 micrograms given to young people aged 18-25, indicating there would be similar levels of protection against serious cases of the virus.

The trial included 4,200 children aged two to six years and 2,500 babies aged six months to two years.

Side effects were generally mild and consistent with those seen in older age groups

The company did, however, find relatively low efficacy against infection, with its trial taking place during the Omicron variant wave.

The current generation of vaccines were designed against the original strain of the virus.

Vaccine efficacy in children six months up to age two was 51 percent, and efficacy was 37 percent in the two to five years age group, when limiting the analysis to only cases confirmed positive on a positive PCR test.

Moderna said these were similar to vaccine efficacy estimates in adults during Omicron, and it is also currently studying booster doses for all pediatric cohorts.

The lower efficacy for two doses has the potential to present a stumbling block to authorization.

Back in February, the Food and Drug Administration (FDA) postponed a meeting of a panel to consider the Pfizer-BioNTech Covid vaccine for children younger than five, saying it wanted to see data on how three doses performed before considering the matter.

The companies said at the time they expected that data to be ready in April, but haven't provided an update since then.

Scientists evaluating a vaccine for infants must closely consider the risk-benefit balance.

Even when they are unvaccinated, children under five are at very low risk for severe disease. There have been only 476 deaths in the United States this age group since the start of the pandemic, according to official data.

Among all US children, there have also been almost 8,000 cases of MIS-C, a post-viral inflammatory condition, that caused 66 deaths.

(T.Burkhard--BBZ)